Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Treatment of Insulin Resistance in Patients With Chronic Hepatitis C Genotype 1 Treated With Peginterferon Alfa-2a in Combination With Ribavirin in Current Clinical Practice

NCT00546442 is registered in ClinicalTrials.gov with Valme University Hospital as lead sponsor.

NCT NCT00546442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00546442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Treatment of Insulin Resistance in Patients With Chronic Hepatitis C Genotype 1 Treated With Peginterferon Alfa-2a in Combination With Ribavirin in Current Clinical Practice
Lead sponsor
Valme University Hospital
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2006
Completion date
January 31, 2007
Enrollment
126 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c